MARKET WIRE NEWS

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD Message Board Post 744878


Posted By: (investorshub) @iHub News

Posted on: Jul/16/2026 14:15:01

Galmed Develops Cardiac-Targeted Aramchol Formulation to Expand Cardiovascular

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177792876


Subscribe to Our Newsletter


Message Board Posts


investorshub : US Market News
investorshub : US Market News
investorshub : US Market News
investorshub : US Market News

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account